Literature DB >> 10880823

Adeno-associated virus vectors: activity and applications in the CNS.

A L Peel1, R L Klein.   

Abstract

Transgenic strategies are useful for functional studies and they may also lead to novel therapies. Controlling transgene expression in defined cell populations over time is increasingly important for both functional and gene therapy experiments. The adeno-associated virus (AAV) vector may provide sufficient spatio-temporal control of gene expression for these purposes. This paper reviews in vivo somatic gene transfer methodology using AAV. Advantageous features of this system include neuronal gene expression that is: (1) efficient; (2) long-lived; and (3) non-toxic. Thus, AAV-mediated gene transfer is a good method for functional genomic research. From characterizing vector activity in the brain using different combinations of promoters and transgenes in the mid to late 1990s, researchers continue to discover novel uses of AAV for both basic and clinical neuroscience.

Entities:  

Mesh:

Year:  2000        PMID: 10880823     DOI: 10.1016/s0165-0270(00)00183-7

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  38 in total

1.  Specific disruption of astrocytic Ca2+ signaling pathway in vivo by adeno-associated viral transduction.

Authors:  Y Xie; T Wang; G Y Sun; S Ding
Journal:  Neuroscience       Date:  2010-08-22       Impact factor: 3.590

2.  Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons.

Authors:  Matthew R J Mason; Erich M E Ehlert; Ruben Eggers; Chris W Pool; Stephan Hermening; Angelina Huseinovic; Eric Timmermans; Bas Blits; Joost Verhaagen
Journal:  Mol Ther       Date:  2010-02-23       Impact factor: 11.454

Review 3.  Current prospects and challenges for epilepsy gene therapy.

Authors:  Marc S Weinberg; Thomas J McCown
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

Review 4.  Gene-based therapies in Parkinson's disease.

Authors:  Patricia J Allen; Andrew Feigin
Journal:  Neurotherapeutics       Date:  2014-01       Impact factor: 7.620

5.  Enhanced expression of Pctk1, Tcf12 and Ccnd1 in hippocampus of rats: Impact on cognitive function, synaptic plasticity and pathology.

Authors:  Ke Wu; Shoudong Li; Karthik Bodhinathan; Craig Meyers; Weijun Chen; Martha Campbell-Thompson; Lauren McIntyre; Thomas C Foster; Nicholas Muzyczka; Ashok Kumar
Journal:  Neurobiol Learn Mem       Date:  2011-09-25       Impact factor: 2.877

Review 6.  Selective Manipulation of Neural Circuits.

Authors:  Hong Geun Park; Jason B Carmel
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 7.  Crossing the blood-brain barrier with AAV vectors.

Authors:  Dan Liu; Mingyang Zhu; Yuqian Zhang; Yong Diao
Journal:  Metab Brain Dis       Date:  2020-11-17       Impact factor: 3.584

8.  AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method.

Authors:  Ronald L Klein; Robert D Dayton; Jason B Tatom; Karen M Henderson; Phillip P Henning
Journal:  Mol Ther       Date:  2007-10-23       Impact factor: 11.454

9.  Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene.

Authors:  Shiou-Lan Chen; Hsin-I Ma; Jun-Ming Han; Ru-Band Lu; Pao-Luh Tao; Ping-Yee Law; Horace H Loh
Journal:  J Biomed Sci       Date:  2010-04-20       Impact factor: 8.410

10.  AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice.

Authors:  Tomomi Kiyota; Masaru Yamamoto; Bryce Schroder; Michael T Jacobsen; Russell J Swan; Mary P Lambert; William L Klein; Howard E Gendelman; Richard M Ransohoff; Tsuneya Ikezu
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.